top of page
Read • watch • learn
Welcome to the Hope Bio Blog




Hope Biosciences Deploying New Cellular Therapeutic for Acute Kidney Injury
FOR IMMEDIATE RELEASE By Jan Shultis Sugar Land, Texas, 3 February 2026 - A multicenter trial stretching across the southwestern United States is now recruiting patients to investigate whether allogeneic (donor-derived) Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) can prevent progression of trauma-induced Acute Kidney Injury (AKI), an abrupt decline in renal function that occurs over hours to days in up to 50% of trauma and burn patients and has few eff
janshultis
Feb 33 min read
bottom of page
